| Date | Title | Description |
| 30.07.2024 | Truvian Health: Lab-Accurate Results Company Raises $74 Million | Truvian Health announced it is redefining the current global infrastructure through its novel platform, creating a world where central laboratory equivalent blood tests are available anywhere you go. Truvian raised $74 million in funding to... |
| 18.07.2024 | Truvian Health Pioneers Accessible Blood Testing with $74 Million Funding Boost | Truvian Health, a groundbreaking healthcare company based in San Diego, California, has recently secured a substantial $74 million in funding to propel its mission of revolutionizing the accessibility of routine blood testing. This signific... |
| 17.07.2024 | Truvian Health Raises $74M to Bring Blood Testing to Anyone, Anywhere | Wittington Ventures and Great Point Ventures lead round
Shoppers Drug Mart, Canada’s largest retail pharmacy chain, joins as a commercial partner
New funding to advance Truvian’s clinical trials to secure FDA clearance for its blood testing... |
| 17.07.2024 | Truvian Health Raises $74M in Funding | Truvian Health, a San Diego, CA-based provider of a blood testing platform, raised $74M in funding.
The round was led by Wittington Ventures and Great Point Ventures, with participation from existing investors, including DNS Capital, Medica... |
| 25.02.2021 | DLA Piper Advises Truvian Sciences in Oversubscribed $105 Million Series C | DLA Piper represented Truvian Sciences in its recent oversubscribed US$105 million Series C financing. The round was led by TYH Ventures, Glen Tullman of 7wireVentures and Wittington Ventures and was joined by General Catalyst, GreatPoint V... |
| 24.02.2021 | Truvian raises $105 million to commercialize its automated blood-testing platform | San Diego, California-based Truvian, a startup developing blood-testing technology that leans heavily on automation, today announced the close of an over $105 million oversubscribed series C round led by TYH Ventures, 7wireVentures’ Glen Tu... |
| 24.02.2021 | Truvian Sciences Raises More Than $105 Million in Oversubscribed Series C Financing | |
| 24.02.2021 | Truvian raises $105 million to commercialize its automated blood-testing platform | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
San Diego, California-based Truvian, a startup de... |
| 24.02.2021 | Truvian Sciences Raises More Than $105M in Series C Financing | Truvian Sciences, a San Diego, CA-based closed more than $105m in a Series C financing.
The round, which brought total funding to more than $150m to date, was led by TYH Ventures, Glen Tullman of 7wireVentures, and Wittington Ventures.
The ... |
| 24.02.2021 | DLA Piper Advises Truvian Sciences in Oversubscribed $105 Million Series C | DLA Piper represented Truvian Sciences in its recent oversubscribed US$105 million Series C financing. The round was led by TYH Ventures, Glen Tullman of 7wireVentures and Wittington Ventures and was joined by General Catalyst, GreatPoint V... |
| 24.02.2021 | Truvian raises $105M, plans to submit benchtop blood-testing tech to FDA | Started by Epic Sciences co-founder Dena Marrinucci in 2015, Truvian says its point-of-care device that can run 36 common wellness tests, including complete blood count, kidney function, and cholesterol and glucose levels.
The idea, CEO Jef... |
| 01.12.2020 | American Healthcare Will Be Fundamentally Different After The Pandemic, And Retail Is Leading The Way | Jeff Hawkins is President and CEO of Truvian Sciences, a healthcare company at the intersection of diagnostics and consumer technology. |
| 04.09.2020 | StartUPDATES: New developments from healthcare startups | Self-insured employers, including several Fortune 500 companies, leverage Carrum Health’s technology-powered COE platform to avoid variation in the cost and quality of surgery and to deliver a superior patient experience. The platform enabl... |
| 04.08.2020 | Founders’ Story: Truvian Sciences | Truvian Sciences CEO Jeff Hawkins and Founder Dena Marrinucci
In a Q&A, Truvian Sciences CEO Jeff Hawkins and Dena Marrinucci, founder and Senior Vice President of Corporate Development and Business Operations, talk about the company’s ... |
| 30.07.2020 | StartUPDATES: New developments from healthcare startups | Truvian Sciences receives FDA Emergency Use Authorization for Easy Check COVID-19 IgM/IgG Test: Rigorously and independently tested and validated, Easy Check exceeds current testing requirements for the detection of IgM/IgG antibodies to SA... |
| 25.11.2019 | Truvian Sciences Raises $27.1M in Series B Financing | Truvian Sciences, a San Diego, CA-based healthcare company at the intersection of diagnostics and consumer technology, closed a $27.1m Series B financing round.
The round, which brought total funds raised to date to $46.3m, was led by Great... |
| 22.11.2019 | Truvian Sciences raises $27m as it tries to succeed where Theranos failed | The idea of a benchtop blood testing system only needing a few drops of blood has gotten a bad rap since Theranos’ collapse. But that hasn’t stopped Truvian Sciences from trying to develop its own system.
The San Diego–based startup announc... |
| 20.11.2019 | Truvian nets $27M to build its comprehensive benchtop blood testing machine
W h i t e p a p e r
Weighing the Costs: | Truvian Sciences raised $27.1 million to fuel the development of its benchtop blood tester, bringing the San Diego-based company’s total funding to date up to $46.3 million.
Sponsored by Agilent Technologies
How would you like to win free b... |
| 20.11.2019 | With echoes of Theranos, Truvian Sciences revives the dream of low-cost, accessible blood tests | A little over a year after the dissolution of the once high-flying blood testing startup Theranos, another startup has raised more than $27 million to breathe new life into the vision of bringing low-cost blood tests to point-of-care medica... |
| 20.11.2019 | Truvian Science announces $27M Series B financing to develop an automated bench-top blood testing system for rapid test results. | - |
| - | Truvian Sciences | “Truvian is disrupting the blood diagnostics industry by developing an easy-to-use, automated benchtop blood testing analyzer. We’re elevating the standards and reimagining blood testing for convenience, simplicity and real-time results.”... |
| - | StartUPDATES: New developments from healthcare startups | Carrum Health, the first digital health company connecting employers and employees to Centers of Excellence (COEs) through a consumer-driven platform for better, more cost-effective healthcare, has expanded its national reach with Mayo Clin... |
| - | StartUPDATES: New developments from healthcare startups | Truvian Sciences receives FDA Emergency Use Authorization for Easy Check COVID-19 IgM/IgG Test: Rigorously and independently tested and validated, Easy Check exceeds current testing requirements for the detection of IgM/IgG antibodies to SA... |
| - | Founders’ Story: Truvian Sciences | Truvian Sciences CEO Jeff Hawkins and Founder Dena Marrinucci
In a Q&A, Truvian Sciences CEO Jeff Hawkins and Dena Marrinucci, founder and Senior Vice President of Corporate Development and Business Operations, talk about the company’s ... |
